Concepedia

Publication | Open Access

Tight control for Crohn’s disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial

DOIFull Paper Access

34

Citations

17

References

2019

Year

Remo Panaccione, Jean–Frédéric Colombel, Simon Travis, Peter Bossuyt, Filip Baert, Tomáš Vaňásek, Ahmet Danalıoğlu, Gottfried Novacek, Alessandro Armuzzi, Walter Reinisch,
Gut

Abstract

NCT01235689; Results.

References

YearCitations

Page 1